tirzepatide cardiovascular outcomes trial 2024 Effects of on the Clinical Trajectory of Patients With Heart Failure Risk of major adverse cardiovascular

Wegovy injections: This is approved to help treat obesity and support weight loss

However, we wont know for certain until head-to-head trials are completed and the medication is approved

Its a similar process to how influenza shots are revised each year

doi: 10.1093/EURHEARTJ/EHAA082 119 BatistaAFBodart-SantosVDe FeliceFGFerreiraST

Semaglutide therapy is contraindicated for individuals with medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and those who are pregnant due to potential adverse fetal outcomes

This does not necessarily mean the medication is ineffective, as appetite suppression usually becomes stronger as the dose increases